The Consumer Product Safety Commission is in over its head with complaints filed by toy makers who argue that they should be exempt from the Consumer Product Safety Improvement Act of 2008, which requires children’s products to undergo stringent and expensive safety testing to ensure reductions in the amount of lead and phthalates used following an influx of lead-tainted toys imported from China in 2007.

After drugmaker GlaxoSmithKline petitioned the FDA Monday to bar dissolvable tobacco products from the market “until their sponsors can demonstrate to FDA that their marketing is appropriate for the protection of public health,” dissolvable tobacco lozenge maker Star Scientific is fighting back by asking the FDA permission to market their product as a lower-risk alternative to smoking.

ACSH staffers were appalled with the abundance of misleading assertions in Dr. Ranit Mishori’s article yesterday in The Washington Post advising readers on the various steps they can take to limit their risk of cancer. Topping her list is maintaining a healthy body weight, because obesity is linked to more than 100,000 cancer cases each year. That’s fair enough, but Dr.

In the search to find the cure for various cancers, three new advances in the field are inspiring hope. The first study hails from Oxford Gene Technology, a genetics and diagnostics firm that has developed a prostate cancer test that can distinguish prostate cancer from benign prostate disease and healthy tissue with 90 percent accuracy.

Balance, leg strength, and impact training may help protect high-risk elderly women from sustaining hip fractures, according to a new study published in yesterday’s Archives of Internal Medicine.

The Federal Trade Commission (FTC) filed a complaint against pomegranate juice maker Pom Wonderful yesterday for making “false and unsubstantiated claims” regarding the supposed health benefits of their juice.

A new study suggests that most men do not need frequent prostate-specific antigen (PSA) tests to screen for prostate cancer after they turn 60, the age at which PSA levels can predict one’s risk of dying from the disease.

Pharmaceutical giant GlaxoSmithKline, maker of the Nicorette nicotine lozenges, urged the FDA on Monday to treat dissolvable smokeless tobacco products made by tobacco companies the same way as pharmaceutical-made smoking cessation products — by keeping them off the market until they “demonstrate to [the] FDA that their marketing is appropriate f

Increasing the tax on alcohol could make us all healthier by reducing drunk-driving deaths, cutting the spread of sexually transmitted diseases and lowering violence and crime, a new meta-analysis claims.